The fourth India-Africa Forum Summit has been postponed due to concerns over the Ebola outbreak in Africa, shedding light on India’s increasing support for the continent’s healthcare needs. The deferment of the summit, originally set for May 28-31, was a result of consultations between India and the African Union amidst the evolving public health situation in Africa.
India’s involvement revolves around the efforts of the Serum Institute of India (SII) in collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) and Oxford University to expedite the development of a vaccine for the Bundibugyo strain of Ebola. Leveraging its established ChAdOx1 vaccine platform, SII aims to produce clinical-grade doses swiftly for upcoming trials.
The report also highlights India’s significant contributions during the Covid-19 pandemic, where the country emerged as a key provider of affordable vaccines to developing nations, including various African countries. Additionally, India’s engagement with Africa extends to humanitarian aid, such as recent food assistance programs for nations grappling with food insecurity and displacement challenges.
India’s support comes at a crucial time as African institutions like the African Union and Africa Centres for Disease Control and Prevention (Africa CDC) coordinate responses to the Ebola outbreak. However, the report emphasizes the continent’s reliance on external partners for vaccine research and large-scale manufacturing, underscoring the necessity for Africa to invest in its biotechnology and vaccine production capabilities for enhanced health security.
